Maiwenn Al

5.1k total citations · 1 hit paper
91 papers, 3.8k citations indexed

About

Maiwenn Al is a scholar working on Economics and Econometrics, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maiwenn Al has authored 91 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Economics and Econometrics, 19 papers in General Health Professions and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maiwenn Al's work include Health Systems, Economic Evaluations, Quality of Life (40 papers), Healthcare Policy and Management (16 papers) and Healthcare cost, quality, practices (11 papers). Maiwenn Al is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (40 papers), Healthcare Policy and Management (16 papers) and Healthcare cost, quality, practices (11 papers). Maiwenn Al collaborates with scholars based in Netherlands, United Kingdom and United States. Maiwenn Al's co-authors include Frans Rutten, Ben A. van Hout, Gilad S. Gordon, Maureen Rutten‐van Mölken, Isaac Corro Ramos, Jan B. Oostenbrink, Talitha Feenstra, Nigel Armstrong, Jos Kleijnen and Johan L. Severens and has published in prestigious journals such as PLoS ONE, Cancer and CHEST Journal.

In The Last Decade

Maiwenn Al

89 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Costs, effects and C/E‐ratios alongside a clinical trial

1994 757 citations Maiwenn Al, Frans Rutten et al. Health Economics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maiwenn Al Netherlands	32	1.2k	589	588	480	411	91	3.8k
Agnès Dechartres France	38	678 0.6×	682 1.2×	417 0.7×	623 1.3×	415 1.0×	149	4.7k
Nicole Mittmann Canada	34	882 0.8×	669 1.1×	391 0.7×	521 1.1×	215 0.5×	190	4.2k
Richard H. Chapman United States	32	1.3k 1.2×	214 0.4×	528 0.9×	528 1.1×	313 0.8×	69	3.9k
Christopher Hyde United Kingdom	39	497 0.4×	597 1.0×	382 0.6×	1.1k 2.3×	413 1.0×	115	5.6k
Jean‐Éric Tarride Canada	35	970 0.8×	452 0.8×	557 0.9×	1.2k 2.5×	313 0.8×	225	4.2k
Neil Hawkins United Kingdom	33	1.1k 0.9×	576 1.0×	355 0.6×	923 1.9×	345 0.8×	150	5.5k
Lotte Steuten Netherlands	29	737 0.6×	629 1.1×	505 0.9×	166 0.3×	189 0.5×	117	2.6k
Robert W. Dubois United States	34	1.0k 0.9×	450 0.8×	635 1.1×	712 1.5×	139 0.3×	169	4.4k
Ivo Abraham United States	39	616 0.5×	816 1.4×	928 1.6×	456 0.9×	548 1.3×	306	6.4k
Pelham Barton United Kingdom	36	959 0.8×	414 0.7×	939 1.6×	622 1.3×	631 1.5×	116	5.4k

Countries citing papers authored by Maiwenn Al

Since Specialization

Citations

This map shows the geographic impact of Maiwenn Al's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maiwenn Al with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maiwenn Al more than expected).

Fields of papers citing papers by Maiwenn Al

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maiwenn Al. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maiwenn Al. The network helps show where Maiwenn Al may publish in the future.

Co-authorship network of co-authors of Maiwenn Al

This figure shows the co-authorship network connecting the top 25 collaborators of Maiwenn Al. A scholar is included among the top collaborators of Maiwenn Al based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maiwenn Al. Maiwenn Al is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Janssen, M., et al.. (2022). Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients. PLoS ONE. 17(1). e0261940–e0261940. 9 indexed citations

Ramos, Isaac Corro, et al.. (2021). Modeling Early Warning Systems: Construction and Validation of a Discrete Event Simulation Model for Heart Failure. Value in Health. 24(10). 1435–1445. 4 indexed citations

Armstrong, Nigel, Nasuh Büyükkaramikli, Rob Riemsma, et al.. (2020). Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 24(51). 1–220. 13 indexed citations

Vreman, Rick A., et al.. (2019). Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia. Applied Health Economics and Health Policy. 17(6). 883–893. 14 indexed citations

Al, Maiwenn, et al.. (2017). Early warning systems for the management of chronic heart failure: a systematic literature review of cost-effectiveness models. Expert Review of Pharmacoeconomics & Outcomes Research. 18(2). 161–175. 4 indexed citations

Voorn, George A.K. van, Pepijn Vemer, Dominique Hamerlijnck, et al.. (2015). The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling. Applied Health Economics and Health Policy. 14(2). 129–133. 32 indexed citations

Vemer, Pepijn, et al.. (2014). Advishe: a New Tool to Report Validation of Health-Economic Decision Models. Value in Health. 17(7). A556–A557. 4 indexed citations

Ramos, Isaac Corro, et al.. (2014). Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis. Value in Health. 18(1). 100–109. 3 indexed citations

Riemsma, Rob, Maiwenn Al, Isaac Corro Ramos, et al.. (2013). SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 17(61). 1–236. 39 indexed citations

10.

Röder, Esther, et al.. (2013). Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. Journal of Allergy and Clinical Immunology. 132(2). 353–360.e2. 214 indexed citations

11.

Al, Maiwenn. (2012). Cost-Effectiveness Acceptability Curves Revisited. PharmacoEconomics. 31(2). 93–100. 30 indexed citations

12.

Wijk, Roy Gerth van, et al.. (2011). AD3 Assessing The Compliance And Persistence of Allergen Immunotherapy In Allergic Rhinitis Using A Retrospective Pharmacy Database From The Netherlands. Value in Health. 14(7). A233–A233. 1 indexed citations

13.

Al, Maiwenn, Leona Hakkaart‐van Roijen, Siok Swan Tan, & Jan Bakker. (2010). Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands. Critical Care. 14(6). R195–R195. 30 indexed citations

14.

McGhan, William F., Maiwenn Al, Jalpa A. Doshi, et al.. (2009). The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report. Value in Health. 12(8). 1086–1099. 57 indexed citations

15.

Nuijten, Mark, Maiwenn Al, & Frans Rutten. (2006). Inter-variable Uncertainty In Decision Analytic Modeling: The Concept Of Second-order Sensitivity. Studies of Applied Economics. 24(3). 711–730. 1 indexed citations

16.

Roijen, Leona Hakkaart‐van, Annemieke van Straten, Maiwenn Al, Frans Rutten, & Marianne Donker. (2006). Cost-utility of brief psychological treatment for depression and anxiety. The British Journal of Psychiatry. 188(4). 323–329. 55 indexed citations

17.

Oostenbrink, Jan B. & Maiwenn Al. (2005). The analysis of incomplete cost data due to dropout. Health Economics. 14(8). 763–776. 85 indexed citations

18.

Sendi, Parham, Maiwenn Al, & Frans Rutten. (2004). Portfolio Theory and Cost-Effectiveness Analysis: A Further Discussion. Value in Health. 7(5). 595–601. 8 indexed citations

19.

Al, Maiwenn, Talitha Feenstra, & Werner Brouwer. (2004). Decision makers’ views on health care objectives and budget constraints: results from a pilot study. Health Policy. 70(1). 33–48. 33 indexed citations

20.

Goldbohm, R. Alexandra, Piet A. van den Brandt, H.A.M. Brants, et al.. (1994). Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer.. PubMed. 48(4). 253–65. 365 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact